SCHEMBL6534445

SCHEMBL6534445

CC(C)C(CO)NS(=O)(=O)c1c(Cl)cc(Cl)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 9/20 0.43
NR3C2 P08235 5/20 0.43
PGR P06401 3/20 0.43
ITGAV P06756 1/20 0.39
ALOX5AP P20292 4/20 0.35
FEN1 P39748 4/20 0.35
PSEN1 P49768 2/20 0.35
PSEN2 P49810 2/20 0.35
APH1B Q8WW43 2/20 0.35
NCSTN Q92542 2/20 0.35
APH1A Q96BI3 2/20 0.35
PSENEN Q9NZ42 2/20 0.35
TRPV3 Q8NET8 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
LMNA P02545 1/20 0.35
PKM P14618 1/20 0.35
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3178938 1.00 NR3C1 (0.43) NR3C1NR3C2PGRITGAVALOX5AP
SCHEMBL3178425 0.80 NR3C1 (0.44) NR3C1NR3C2PGRITGAVALOX5AP
SCHEMBL3177089 0.76 MMP2 (0.55) CA1CA2CA7CA9
SCHEMBL3180002 0.76 RAB9A (0.51) NR3C1TRPV3CA1CA2CA7
SCHEMBL3214337 0.76 NR3C1 (0.39) NR3C1NR3C2PGRITGAVCA1
SCHEMBL3220617 0.74 NR3C1 (0.44) NR3C1NR3C2PGRITGAVCA2
SCHEMBL3220629 0.74 NR3C1 (0.45) NR3C1NR3C2PGRCYP3A4
SCHEMBL5143422 0.74 NR3C1 (0.39) NR3C1NR3C2PGRITGAVALOX5AP
SCHEMBL14132608 0.70 CA1 (0.53) NR3C1NR3C2PGRCA1CA2
SCHEMBL1168623 0.70 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006050-A1 Substituted phenylsulfonamide inhibitors of beta amyloid production WYETH (US) 2004-01-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006050-A1 Substituted phenylsulfonamide inhibitors of beta amyloid production APP, BACE1, PSEN1 NR3C1 2513/4885NR3C2 2576/4885PGR 3315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.